Navigation Links
DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
Date:6/16/2010

emarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.

DURECT Forward-Looking Statement

The statements in this press release regarding the potential uses and benefits of POSIDUR, indications of clinical efficacy and safety of POSIDUR, the design of BESST and overall NDA strategy and possible royalties and milestone payments receivable from our collaborations with Nycomed and Hospira are forward-looking statements involving risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements.  Potential risks and uncertainties include, but are not limited to, our and our collaborators' difficulty or failure to obtain approvals from regulatory agencies with respect to clinical trials and other development activities, or  design, enroll, conduct and complete clinical trials, failure of such clinical trials to produce intended results or to confirm results from earlier clinical trials, possible adverse events associated with the use of POSIDUR, delays and costs due to additional work or other requirements imposed by regulatory agencies for continued development, approval or sale of POSIDUR, our ability to complete the design, development, and manufacturing process development of POSIDUR, and to manufacture, commercialize and obtain marketplace acceptance of POSIDUR, and avoid infringing patents held by other parties and secure and defend patents of our own, and manage and obtain capital to fund our growth, operations and expenses. Further information regarding these and other risks is included in DURECT's Form 10-Q filed on May 10, 2010 under the heading "Risk Factors."


'/>"/>
SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. DURECT Announces Positive ELADUR(TM) Phase IIa Study Results
2. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
3. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
4. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
5. DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
6. DURECT Corporation Invites You to Join Its Fourth Quarter 2009 Earnings Conference Call
7. DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
8. DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results
9. DURECT to Present at the Cowen and Company Healthcare Conference
10. DURECT to Present at the Barclays Capital Global Healthcare Conference
11. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Kan. , July 24, 2014  Parnell ... two compounds that will be added to Parnell,s ... Australian-based CIMTECH Pty Ltd, a biotechnology company. The ... 122 have shown promise in bone regeneration and ... to develop the compounds for the veterinary market ...
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
(Date:7/24/2014)... 24, 2014 Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... 31, to discuss the Company,s Second Quarter 2014 ... 2014 earnings conference call and webcastWhen: , ... Lipps, chairman, president and chief executive officer ...
Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... Get employees moving to improve health with MapWalk ... www.hesonline.com ). The company makes this fun, easy tool free to wellness program ... , , ... , Using Google Maps ...
... June 3 Today, Roche honored 11 outstanding Ph.D. students ... for research accomplishments in the field of organic chemistry. The winners are ... Chemistry to gain first hand knowledge on the important role organic ... , , ...
Cached Medicine Technology:Exclusive Mapping Tool Helps Create Walking Communities 2Exclusive Mapping Tool Helps Create Walking Communities 3Roche Symposium Showcases Accomplishments of Next Generation of Chemists 2Roche Symposium Showcases Accomplishments of Next Generation of Chemists 3Roche Symposium Showcases Accomplishments of Next Generation of Chemists 4Roche Symposium Showcases Accomplishments of Next Generation of Chemists 5
(Date:7/25/2014)... Houston, TX (PRWEB) July 25, 2014 ... Annual Family Fun Fest on Sunday, July 27 at ... franchises include Memorial, Copperfield, Katy, Pearland, Friendswood, Spring, ... location in The Heights. , “We’re thrilled to ... this year,” said Heather Belcher who owns the Sugarland-Missouri ...
(Date:7/25/2014)... ON (PRWEB) July 25, 2014 Art of ... providing services to those in Toronto who are looking for ... a study done by the American Academy of Facial ... of 2014, interest in facial plastic surgery showed a surprising ... jobs rose 10 percent, while hair transplants increased by 7 ...
(Date:7/25/2014)... 2014 Parker Waichman LLP, a national ... comments on a recent tobacco lawsuit in which a ... billion in punitive damages. Cynthia Robinson brought the lawsuit ... case is Cynthia Robinson v. R.J. Reynolds Tobacco Company ... Circuit Court, Escambia County, Florida; Case Number 2008 CA ...
(Date:7/25/2014)... 2014 Hastings and Hastings, a ... fees with regard to personal injury claims, announces free ... range of legal services for those that have been ... individual or corporation. Free initial consultation services gives clients’ ... a potential personal injury claim . It also ...
(Date:7/25/2014)... seem to learn even before they,re born, a new ... weeks pregnant, their unborn babies can respond to the ... rhyme, the researchers report. "The mother,s voice is ... fetus," Charlene Krueger, nursing researcher and associate professor in ... a university news release. "This research highlights just how ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Rhymes Reveal Evidence of Learning in the Womb 2
... ... Baele, makes a great case for buying your Mother a spa for Mother,s Day this weekend at ... for them 24/7 365 days a year just outside the back door... , ... (PRWEB) May 5, 2010 -- Give her a gift that will last ...
... to the naked eye at least they are ... however, scientists are able to make electrical signals visible. ... from the Max Planck Institute for Medical Research in ... electrical activity in neurons of living mice. In a ...
... for potential deadly complications , WEDNESDAY, May 5 (HealthDay ... caused by kidney failure increase the risk for cardiovascular ... found. , A meta-analysis of 27 trials, which included ... known as erythropoiesis-stimulating agents (ESAs), found that those who ...
... ... North America are urging consumers to “get to know your water.” , ... Denver, CO (Vocus) May 5, 2010 -- During ... across North America are urging consumers to “get to know your water.”, , , , ...
... ... who will be practicing primarily at the Greeneville location., , ... Greeneville, Tennessee (PRWEB) May 5, 2010 -- A prominent East ... located at 3465 East Andrew Johnson Highway., , ,The law firm’s connections to Greene County ...
... ... leading social expressions retailer, is offering a special edition of a complimentary Mothers’ ... stores. PAPYRUS is partnering with Recipes for Life™, a company that creates ... greeting card customers with a deeper way to celebrate life events, free of ...
Cached Medicine News:Health News:Buy Ma a Spa for Mothers Day This Weekend at Market Hall in Dallas at the Spa, Pool and Sauna Show 2Health News:Blinking neurons give thoughts away 2Health News:Blinking neurons give thoughts away 3Health News:Anemia Drugs Hold Dangers for Kidney Patients 2Health News:Anemia Drugs Hold Dangers for Kidney Patients 3Health News:During Drinking Water Week 2010, Water Suppliers Invite Public to 'Get To Know Your Water' 2Health News:Prominent East Tennessee Law Firm Opens Greene County Office 2Health News:Prominent East Tennessee Law Firm Opens Greene County Office 3Health News:PAPYRUS Offers Complimentary Recipes for Life Cards to Celebrate Mother's Day 2
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... Rapid Screen Tests are used by ... help analyze many human health conditions. The ... flow membrane tests, which are offered in ... formats and flow through membrane tests are ...
... The CALBIOTECH INC. (CBI) Prolactin ELISA ... of prolactin in human serum or plasma. ... chain polypeptide hormone with a molecular weight ... is based on a solid phase direct ...
... a polypeptide hormone secreted in significant amounts ... placenta. Prolactin, in synergy with estrogen, plays ... and maintenance of mammary gland growth and ... may have effects on cell growth in ...
Medicine Products: